Literature DB >> 25616969

An analysis method for simultaneous screening of deoxyribonucleic acid-binding active compounds and investigating their mechanisms by ultra-fast liquid chromatography tandem mass spectrometry coupled with fluorescence detection technology.

Cangman Zhang1, Biao Ren2, Zongtao Lin3, Lingkun Tong2, Hong Wang4, Shizhong Chen5.   

Abstract

DNA has been known as the cellular target for many cytotoxic anticancer agents over the years. Discovering DNA-binding compounds has become an active research area, while various DNA-binding mechanisms make the drug discovery even more difficult. In this article, we present a novel analysis method to rapidly identify specific DNA-binding compounds from Pyrrosia lingua (Thunb.) using DNA-dual-fluorescent probes, ethidium bromide and Hoechst 33258, with the technology of ultra-fast liquid chromatography-diode array detector-tandem mass spectrometry and dual-wavelength fluorescence detector (UFLC-DAD-MS(n)-DFLD). Sixty-two compounds were identified, of which 22 were found to be active in DNA-binding. After investigation of their dose-response behaviors and structure-activity relationships, chlorogenic acids and flavonoid glycosides were found to be DNA-binders via both minor groove-binding and intercalation modes. The precision, reproducibility and stability of this method were validated by vitexin. The established system was sensitive, precise, and reliable to be used for both screening of DNA-binding compounds and investigating of their mechanisms.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  DNA-binding; Ethidium bromide; Hoechst 33258; Pyrrosia lingua (Thunb.); UFLC-MS

Mesh:

Substances:

Year:  2015        PMID: 25616969     DOI: 10.1016/j.chroma.2015.01.019

Source DB:  PubMed          Journal:  J Chromatogr A        ISSN: 0021-9673            Impact factor:   4.759


  1 in total

1.  Rapid Screening of Potential Phosphodiesterase Inhibitors from the Roots of Ilex pubescens Hook. et Arn. Using a Combination of Ultrafiltration and LC-MS.

Authors:  Zichen Liu; Zongtao Lin; Shizhong Chen; Lingjun Wang; Shaoxiang Xian
Journal:  Evid Based Complement Alternat Med       Date:  2017-03-23       Impact factor: 2.629

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.